Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

The Lancet

Volumn 335, Issue 8705, 1990, Pages 1544-1547

  Galli, M ^a   Barbui, T ^a   Comfurius, P ^b   Maassen, C ^b   Hemker, H C ^b   Zwaal, R F A ^b   Bevers, E M ^b   de Baets, M H ^c   van Breda Vriesman, P J C ^c  

^a OSPEDALI RIUNITI   (Italy)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PLASMA PROTEIN; PROTEIN;

ARTICLE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODY AFFINITY; AUTOANTIBODIES; BLOOD COAGULATION FACTORS; BLOOD PROTEINS; CARDIOLIPINS; CHOLESTEROL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN; LIPOSOMES; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGE; MOLECULAR WEIGHT; PEPTIDES; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLSERINES; SUPPORT, NON-U.S. GOV'T;

EID: 0025302635     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(90)91374-J     Document Type: Article

References (13)

1. Lupus anticoagulants and thrombosis
2. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
3. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay: standardization and quantitation of results
4. Report of the working party on acquired inhibitors of coagulation: studies of "lupus" anticoagulant
5. Prothrombin as co-factor of the circulating anticoagulant in systemic lupus erythematosus?
6. Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus
7. Cofactor of the "lupus anticoagulant"
8. Lupus anticoagulant
9. The 1982 revised criteria for the classification of systemic lupus erythematosus
10. Immunological specificity and mechanism of action of IgG lupus anticoagulants
11. A rapid, sensitive and versatile assay for protein using coomassie brilliant blue G 250
12. Anticardiolipin antibodies and lupus anticoagulants comprise antibody subgroups with different phospholipid binding characteristics
13. 2-glycoprotein I